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Abstract: In survival analysis, Cox model is widely used for most clinical trial data.
Alternatives include the additive hazard model, the accelerated failure time (AFT)
model and a more general transformation model. All these models assume that the
effects for all covariates are on the same scale. However, it is possible that for dif-
ferent covariates, the effects are on different scales. In this paper, we propose a shape-
invariant hazard regression model that allows us to estimate the multiplicative treatment
effect with adjustment of covariates that have non-multiplicative effects. We propose
moment-based inference procedures for the regression parameters. We also discuss the
risk prediction and goodness of fit test for our proposed model. Numerical studies show
good finite sample performance of our proposed estimator. We applied our method to
Veteran’s Administration (VA) lung cancer data and the HIVNET 012 data. For the
latter, we found that single-dose nevirapine treatment has a significant improvement
for 18-month survival with appropriate adjustment for maternal CD4 counts and virus
load.
Primary 62N01, 62N02, 62P10.
Keywords and phrases: Censoring, Counting processes, Semiparametric methods,
Time-to-event analysis.
1. Introduction
An important HIV/AIDS randomized prevention trial was conducted between Novem-
ber 1997 and January 2001 (Jackson et al. 2003). This trial was named as HIVNET
012 and the goal was to evaluate the efficacy and the safety of a short course nevirapine
(NVP) treatment compared to a short course zidovudine (AZT) treatment for pregnant
mothers during labor and delivery. The primary clinical endpoint is the mother-to-child
transmission (MTCT) of human immunodeficiency virus type-1 (HIV-1) and the sec-
ondary endpoint is the 18-months infant survival. As is shown in Chen et al. (2012),
the NVP seems improving survival over time when looking at the Kaplan-Meier curve.
Cox regression analysis also suggests that the NVP would reduce hazard by 26.0% but
this improvement is not statistically significant (p>0.20). So it is natural to ask whether
there is alternative models to detect the treatment effect. For this data, we considered
two important covariates, maternal HIV-RNA viral loads (VLs) and maternal CD4+
counts at baseline. However, we did not restrict the covariate to be time-independent
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and follow-up VLs and CD4+ counts can be used when trying to identify the mecha-
nism how the treatment works. Another possible time-dependent covariate, for exam-
ple, is the interaction between time and treatment assignment.
In survival analysis of censored time-to-event outcomes, Cox model (Cox 1972) is
most commonly used due to its simple mathematical structure in terms of its parame-
ter estimation, asymptotic result etc. The additive hazard model (Lin and Ying 1994)
was proposed so as the covariates’ effect on hazard is treated as additive, rather than
multiplicative. An alternative model, the accelerated failure time model (AFT; Zeng
and Lin 2007), is commonly used in the field of engineering or physics (i.e. reliability
assessment) given the better scientific explanation of its coefficients. However, all the
models above require that different covariates have the same type of effects on the uni-
fied transformed scale. It is possible that different risk factors have different kinds of
effects; modeling all variables’ effects in the same scale might be inappropriate.
We denote the treatment indicator as Z and denote the two covariates as X1 and X2.
The traditional Cox regression model has the following hazard function form:
λ(t |Z,X1, X2) = λ0(t) exp{γZ + β1X1 + β2X2}, (1)
where λ0(·) is an unknown baseline hazard function and γ, β1, β2 are parameters of
interest. One important feature of this model is that the marginal hazard, as well as
the marginal survival curve, cannot cross-over between different groups defined by
covariates. However, for real data, the Kaplan-Meier curves often have some cross-
overs and this indicates that these simple models may not be sufficient.
Several models have been proposed to model different kinds of effects. Lin and
Ying (1995) proposed an additive-multiplicative hazard model that allows two kinds
of effects. Chen and Jewell (2001) proposed an accelerated hazard model which is
a flexible model allowing effects in both multiplicative hazard scale and time scale
change. Combining the effects allowed in these two models, we have the following
hazard form:
λ(t |Z,X1, X2) = λ0(teβ1X1)eβ1X1eγZ + β2X2. (2)
We use this model since it allows the survival functions for different levels of Z to have
cross-over, which is the case for many real data problem.
In this paper, we propose a broader class of model that allows all three kinds of
effects. To make the interpretation of each parameter clear, our method focus on the
cases where covariates are different for different effects in the main part of the paper
followed by a discussion on the extension to allow same covariate have different kinds
of effects. Besides estimating the effect of certain covariate, our model is useful to make
prediction because it is closer to a nonparametric model and has fewer restrictions for
the survival curves between different groups defined by covariates.
We organize the paper as follows. In section 2, we propose a shape invariant hazard
model. In section 3, we present the inference method with asymptotic results. In sec-
tion 4, we perform numerical study to evaluate the finite sample performance of our
estimator. In section 5, we apply our method to the VA lung cancer data and HIVNET
012 data. In section 6, we provide more discussion of the model.
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2. The Shape-Invariant Hazard Regression Model
To make model (2) general, we, mathematically, treat Z , X1 and X2 all as covariate.
We denote Z = (Z1,Z2,Z3), and propose the following “Shape-Invariant" hazard
model:
λ(t |Z) = λ0(teβ1Z1)eβ1Z1eβ2Z2 + β3Z3, (3)
where β = (β1,β2,β3) are unknown parameters of interest.
When Z2 and Z3 are potentially time-varying, we propose the following model:
λ(t |Z) = λ0(teβ1Z1)eβ1Z1eβ2Z2(t) + β3Z3(t). (4)
Here Z1, Z2(t), Z3(t) are assumed to be different. So for this model, we have an
accelerated time effect from Z1, then a multiplicative hazard effect from Z2(t) and
finally an additive effect from Z3(t). An important feature for this model is that for
any subgroup defined by Z1 and Z2, the model is an additive risk model with respect
to Z3. But the model is not a Cox model for some subgroups defined by Z1 and Z3. It
is only a Cox model respect to Z2 for the subgroup with Z3 = 0. Also, the model is an
AFT model respect to Z1 only in the subgroup with Z2 = 0 and Z3 = 0.
We denote the derivative of the baseline hazard as λ˙0(t). To make β in model (4)
identifiable, we need that for some t,
[λ0(te
β1Z1) + teβ1Z1 λ˙0(te
β1Z1)]Z1e
β1Z1+β2Z2(t)
λ0(te
β1Z1)Z2(t)e
β1Z1+β2Z2(t)
, and Z3(t) are linear independent at true parameter.
When the joint distribution of Z1,Z2,Z3 are non-degenerate, this assumption holds.
The cumulative hazard function of our proposed model has the following form:
Λ(t |Z) =
∫ t
0
[eβ2Z2(u)dΛ0(ue
β1Z1) + β3Z3(u)du], (5)
where Λ0(·) is the baseline cumulative hazard function. WhenZ2 is time-independent,
which is true when Z2 is treatment indicator, we have
Λ(t |Z) = eβ2Z2Λ0(teβ1Z1) + β3
∫ t
0
Z3(u)du. (6)
3. Inference
In this section, we give moment-based inference procedures for our proposed shape-
invariant hazard model. We give the estimator, followed by the asymptotic result. Then,
we discuss the prediction and test for goodness fit of the model.
3.1. Estimation of Survival Parameters
Here, we estimate the survival parameters with moment-based estimation procedure.
Denote the event time as T and the censoring time as C, then the observed composite
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endpoints are T ∗ = T ∧ C and ∆ = I(T ≤ C). Using traditional counting process
notation, we denote Yi(t) = I(T ∗i ≥ t) and Ni(t) = I(∆i = 1, T ∗i ≤ t). We denote
our data as X = {Yi(t), Ni(t),Zi(t), t ∈ [0,∞), i = 1, 2, · · · , n}. We define the
filtration as
Ft = σ{Yi(s exp(−β10Z1i)), Ni(s exp(−β10Z1i)),Z1i,Z2i(s),Z3i(s),
s ∈ [0, t], i = 1, · · · , n}.
We denote the true parameter as β0 = (β10,β20,β30). Noticing
E[dNi(te
−β10Z1i)|Ft−;β0]
= Yi(te
−β10Z1i)[λ0(t)e
β20Z2i(t) + β30Z3i(t)e
−β10Z1i ]dt, (7)
we can obtain a moment-based estimator for baseline hazard function given regression
parameters as
Λ̂0(t;β) =
∫ t
0
∑
i[dNi(se
−β1Z1i)− Yi(se−β1Z1i)β3Z3i(s)e−β1Z1ids]∑
i Yi(se
−β1Z1i)eβ2Z2i(s)
. (8)
We choose different Wi(t) and denote W (t;β) =
∑
j Wj(t)Yj(te
−β1Z1j )eβ2Z2j (t)
∑
j Yj(te
−β1Z1j )eβ2Z2j(t)
, then
we can solve the following unbiased estimating equation,
0 =
∑
i
∫
{[Wi(t)−W (t;β)][dNi(te−β1Z1i)− Yi(te−β1Z1i)β3Z3i(t)e−β1Z1idt]},
(9)
to obtain a consistent estimator of β. When Z1, Z2 and Z3 are different, it is natural
to use them as the weight function. For simplicity, we assume the weight does not
depend on unknown parameters or empirical distribution of the survival time for whole
population.
Theorem 1: Under regularity conditions listed in supplementary materials, we have
√
n(β̂ − β0) D−→ N(0,Σ). (10)
The proof of Theorem 1 are given in the supplementary materials.
3.2. Model-Based Prediction
For prediction purposes, similar to the Cox model (Lin et al. 1994), the AFT model
(Park and Wei 2003) and the additive risk model (Shen and Cheng 1999), pointwise
confidence interval as well as the simultaneous confidence bands can be constructed.
For pointwise confidence interval, as we have the central limit theory for β̂ and Λ̂(t),
the only thing we need to know is the joint distribution of these two quantities to obtain
a standard error estimation v(t) = ŜE of our estimated cumulative hazard function
Λ̂(t|Z) =
∫ t
0
[eβ̂2Z2(u)dΛ̂0(ue
β̂1Z1) + β̂3Z3(u)du], (11)
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where the baseline hazard is estimated by Λ̂0(t) = Λ̂0(t, β̂). When Z is time indepen-
dent, this can be simplified by
Λ̂(t|Z) = Λ̂0(teβ̂1Z1)eβ̂2Z2 + β̂3Z3t. (12)
Then the point-wise confidence interval can be calculated by Λ̂(t|Z) ± z1−α/2v(t),
where z is the critical value from standard normal distribution and α is significant
level. We can obtain v̂(t) from simple Bootstrap method. Similarly, we can have the
following type of confidence bands Λ̂(t|Z) ± c(α)v(t),where c(α) is obtained from
Bootstrap sample.
3.3. Model Adequacy Assessment
We consider Kolmogorov-Smirnov Test and Gill-Schumacher Test to assess our model
fit. We can compare the model based fitted cumulative hazard to the nonparametric
fitted one. This method is not preferred whenZ is time-varying. When Z is time inde-
pendent, we define the test statistics as
D(t, β̂,Z) = n−1/2
∫ t
0
Q(u, β̂,Z)d[Λ̂(u|Z)− Λ̂NP (u|Z)] (13)
where Q(·, ·, ·) is an arbitrary weight function. Here Λ̂NP (u|Z) denotes the cumula-
tive hazard function estimated nonparametrically. One such estimator is the Kernel-
Smoothed Kaplan-Meier estimator (Akritas, 1994) in the following form:
Λ̂NP (u|Z) =
∫ u
0
n−1
∑n
i=1Kh(Zi − z)dNi(t)
n−1
∑n
i=1Kh(Zi − z)I(Yi ≥ t)dt
, (14)
where Kh(x) = K(x/h)/h. Here K(·) is a given symmetric smooth kernel density
function and h is the bandwidth such that nh2 → ∞ and nh4 → 0 as n → ∞. We
can use D1(β̂) = supt,Z|D(t, β̂,Z)| or D2(β̂) = supt|
∫
D(t, β̂,Z)dF̂Z | where F̂Z
is the empirical distribution of Z. A very large test statistics suggests that the model is
not adequate to fit the data.
Another test we considered here is the Gill-Schumacher Test. For any weightW1i(t)
and W2i(t), we can obtain estimators by solving the score equation S1(β) = 0 and
S2(β) = 0 to obtain β̂(1) and β̂(2). It is straightforward to use the test statistics
β̂(1) − β̂(2), but the variance of this statistics is difficult to compute. So using the
similar estimator as in Chen (2001), we also consider the score test. Since we have that
under the null, n−1/2(S1(β0), S2(β0)) follows joint normal distribution with covari-
ance matrix Σ12, which can be estimated using Bootstrap method. So we can use test
statistics
TGS = minβ∈U(β̂(1))
[(
S1(β)
S2(β)
)T
Σ̂−112
(
S1(β)
S2(β)
)]
, (15)
which follows χ2p distribution asymptotically to assess model fitting.
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4. Numerical Studies
4.1. Numerical Estimation Procedure
Since the estimating equation contains an integration including Y (t), which does not
have a close form, we choose 1000 equal space points to evaluate the integration nu-
merically. Since the estimating equation is not differentiable, we use recursive bisector
search for the solution that minimize the absolute value of the estimating equations. We
need to estimate the variance based on the linear approximation. However, such approx-
imation contains λ(t) and λ˙(t), which can only be estimated via kernel smoothing and
is not stable with finite sample size. So we use a numerical method as given in Chen
and Jewell (2001) to estimate variance. If we denote the normalized estimating equa-
tion by 0 = S(β), we estimate the variance matrix Σ̂ of S(β) by n−1
∑n
i=1 Si(β̂)
⊗2
.
We consider the following decomposition Σ̂ = BBT , where B = (b1, b2, · · · , bp).
Then we use the following expression for variance estimator
(S−1(n−1/2b1)− β̂, · · · , S−1(n−1/2bp)− β̂)⊗2.
4.2. Simulations
In order to evaluate the finite sample performance of our proposed estimator, we per-
formed simulations as shown below. We chose the baseline hazard as 1/(1 + t). We
considered Z = (Z1, Z2, Z3) where Z1, Z2 and Z3 independently follow bernoulli
distribution with parameter 0.5 or follow standard uniform distributions. The censor-
ing distribution is an exponential distribution with appropriate rate to making about
30% or 50% censoring. We ran 100 simulations for each setting and summarized the
bias, empirical SE, mean estimated SE. The simulation results are summarized in Table
1-2. From the tables, we can see that our proposed estimator is unbiased. The estimated
SE is generally comparable to the empirical one and the empirical SE increases when
the censoring rate increases.
We found that the numerical variance estimator is not stable even for large sample
size. This might be due to the fact that the numerical method is essentially smoothing
with uniform kernel and the kernel estimator is not stable with finite sample size. But
we found that the variance can be estimated precisely with Bootstrap technique even
for a relatively small sample size (n=200). Thus in data analysis, though computational
extensive, we recommend using Bootstrap for variance estimation.
5. Real Data Examples
In this section, we illustrate our method by applying it to two data sets.
5.1. Example 1: VA Lung Cancer
A well known data set in survival analysis is the Veterna’s Administration lung cancer
trial data from Kalbfleisch and Prentice (1980). The covariates used are the Karnofsky
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Censoring True β
n=200
Bias Est SE Emp SE
β1 β2 β3 β1 β2 β3 β1 β2 β3
30% 0,0,0.1 0.03 -0.02 0.01 0.26 0.07 0.03 0.34 0.20 0.09
0,0,0.2 0.04 -0.02 0.00 0.29 0.08 0.05 0.35 0.21 0.11
0,-0.5,0.1 0.03 -0.03 0.00 0.29 0.08 0.03 0.37 0.21 0.07
0,-0.5,0.2 0.02 -0.03 0.00 0.30 0.08 0.03 0.38 0.22 0.08
0.5,0,0.1 0.01 -0.02 0.01 0.27 0.06 0.04 0.31 0.19 0.10
0.5,0,0.2 0.01 -0.02 0.00 0.25 0.07 0.04 0.33 0.20 0.13
0.5,-0.5,0.1 -0.01 -0.03 0.00 0.29 0.09 0.04 0.35 0.20 0.08
0.5,-0.5,0.2 -0.01 -0.03 0.00 0.28 0.09 0.05 0.36 0.21 0.10
50% 0,0,0.1 0.05 -0.03 0.02 0.30 0.09 0.04 0.36 0.24 0.12
0,0,0.2 0.05 -0.03 0.01 0.33 0.10 0.06 0.37 0.25 0.15
0,-0.5,0.1 0.04 -0.03 0.01 0.27 0.10 0.03 0.40 0.24 0.09
0,-0.5,0.2 0.04 -0.03 0.00 0.29 0.09 0.04 0.40 0.26 0.12
0.5,0,0.1 0.04 -0.02 0.04 0.29 0.10 0.05 0.34 0.23 0.13
0.5,0,0.2 0.03 -0.02 0.02 0.26 0.08 0.05 0.34 0.25 0.17
0.5,-0.5,0.1 0.01 -0.03 0.02 0.23 0.07 0.03 0.35 0.23 0.11
0.5,-0.5,0.2 0.02 -0.03 0.01 0.31 0.09 0.05 0.35 0.25 0.14
TABLE 1
Simulation results for sample size 200 for the baseline hazard 1/(1 + t), binary covariates, with different
true β and censoring rate from 100 simulations
Censoring True β
n=500
Bias Est SE Emp SE
β1 β2 β3 β1 β2 β3 β1 β2 β3
30% 0,0,0.1 0.01 0.02 -0.01 0.20 0.06 0.03 0.18 0.10 0.05
0,0,0.2 0.01 0.02 -0.01 0.26 0.06 0.04 0.20 0.11 0.06
0,-0.5,0.1 0.01 0.01 0.00 0.24 0.07 0.03 0.20 0.10 0.04
0,-0.5,0.2 0.01 0.01 0.00 0.22 0.07 0.03 0.21 0.11 0.05
0.5,0,0.1 0.01 0.02 -0.01 0.18 0.05 0.03 0.18 0.10 0.06
0.5,0,0.2 0.00 0.02 -0.01 0.20 0.06 0.05 0.19 0.10 0.07
0.5,-0.5,0.1 0.00 0.01 0.00 0.22 0.07 0.03 0.20 0.10 0.05
0.5,-0.5,0.2 0.00 0.01 -0.01 0.22 0.09 0.05 0.21 0.11 0.06
50% 0,0,0.1 0.01 0.02 0.00 0.18 0.06 0.03 0.20 0.12 0.07
0,0,0.2 0.02 0.01 -0.01 0.27 0.08 0.05 0.22 0.13 0.08
0,-0.5,0.1 0.01 0.01 0.00 0.22 0.07 0.03 0.22 0.13 0.06
0,-0.5,0.2 0.01 0.01 0.00 0.23 0.07 0.04 0.24 0.14 0.07
0.5,0,0.1 0.01 0.01 0.00 0.13 0.05 0.04 0.19 0.12 0.08
0.5,0,0.2 0.00 0.01 0.00 0.24 0.07 0.06 0.20 0.12 0.10
0.5,-0.5,0.1 0.01 0.01 0.00 0.16 0.07 0.03 0.21 0.12 0.07
0.5,-0.5,0.2 0.02 0.01 0.00 0.18 0.07 0.04 0.22 0.13 0.08
TABLE 2
Simulation results for sample size 500 for the baseline hazard 1/(1 + t), binary covariates, with different
true β and censoring rate from 100 simulations
score and the cell types. Because the additive effect magnitude depends on the time
scale, here we choose 100 days as one unit in the analysis. Previous analysis showed
that the proportional hazard assumption does not hold for Karnofsky score. According
to our data, the proportional hazard assumption holds for some cell types. Thus we
still model Karnofsky score with a multiplicative effect, but assumed cell types to have
different kinds of effects. For illustration purpose, we used large and squamous types
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as reference group and fit an accelerated effect for the small type and fit an additive
hazard effect for the adeno type. The fitted coefficients are given in Table 3 and the
results suggest all three effects are significant.
Variable Effect Type Coef SE 95% CI
Small type Time Scale 0.94 0.19 0.55 1.31
Karnofsky score (20) Multiplicative -0.75 0.21 -1.28 -0.51
Adeno type Additive 0.09 0.04 0.01 0.18
TABLE 3
Result for VA Lung Cancer Data
5.2. Example 2: HIVNET 012
We applied our method to the HIV-NET012 data. We dichotomized the maternal CD4+
counts and virus load at cut point 350 and 50,000. Here we use the time unit as 1,000
days. We first fit models that restrict all covariates to have the same type of effects,
i.e. AFT model, Cox model or additive hazard model. Then we put in variables of our
primary interest, which are the treatment in Cox part and virus load in time scale part
and CD4+ counts in additive part. From Table 4, we see that the effect of Nevirapine
is not statistically significant in all the models assuming same type of effects for virus
load and CD4+ counts adjustment. But our proposed model shows that Nevirapine
has a significant improvement in reducing hazard compared to AZT. The fitted curve is
Variable Effect Type Coef SE 95% CI
High VL Time Scale 1.89 0.42 1.06 2.72
Not use Nevirapine Time Scale 0.35 0.39 -0.42 1.12
Low CD4 Time Scale 0.46 0.37 -0.27 1.20
High VL Multiplicative 0.98 0.20 0.58 1.37
Not use Nevirapine Multiplicative 0.18 0.20 -0.22 0.57
Low CD4 Multiplicative 0.24 0.19 -0.13 0.62
High VL Additive 0.14 0.03 0.08 0.20
Not use Nevirapine Additive 0.03 0.03 -0.03 0.08
Low CD4 Additive 0.03 0.02 -0.02 0.07
High VL Time Scale 2.05 1.23 -2.48 2.71
Not use Nevirapine Multiplicative 0.68 0.32 0.05 1.34
Low CD4 Additive 0.02 0.02 0.00 0.06
TABLE 4
Result for HIV-NET Data
plotted in Figure 1 in comparison with the KM curve for each subgroup defined by virus
load and CD4+ counts level. The time scales are different between the plots at left and
those at right because we have a large estimated time scale change parameter. When
looking at the Kaplan-Meier for longer period of time for the two groups with high
virus load, there are signs of effect modification by time. However, when adding that
interaction term into the model, its coefficient is -0.42 and is not statistically significant.
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FIGURE 1. Comparing model fitted survival curve with the Kaplan-Meier Curve for each subgroup defined
by virus load and CD4+ level: red line is model fitted; black line is Kaplan-Meier; solid line is nevirapine
group; dotted line is AZT
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6. Discussion
6.1. Same covariate for different effects
In this paper, we consider the case where Z1, Z2 and Z3 are different. In general,
we can allow them to be the same. But we need to use different weight to estimate
the effects. When the Zs are the same for the three parts, the model is a higher level
model that includes Cox model, AFT model and additive risk model. We can use this
shape invariant model to test the goodness of fit for these models. When there are some
common covariates in different parts of the model, the interpretation is slightly differ-
ent. The model can have different signs for β2, β3 to allow cross over for the survival
curve in different groups. In fact, even in real data, there are some examples where
we expect the signs to be different. In this case, there are different pathways and the
effects are in opposite sign in these pathways. However, there are some identifiability
concerns when Zs are the same. When the baseline hazard follows Weibull distribu-
tion with hazard λ(x) = CxK , if we have univariate Z , then the above quantities
become C(K + 1)tKZe[(K+1)β1+β2]Z , CtKZe[(K+1)β1+β2]Z and Z . Since the first
two terms are exactly collinear, the model is not identifiable Also, the model is not
identifiable when Z is univariate and the true β1 = 0, since the three quantities become
[λ0(t) + tλ˙0(t)]Ze
β2Z
, λ0(t)Ze
β2Z and Z where the first two are collinear. To verify
the identifiability for univariateZ in general is difficult and simulation shows that there
is multiple roots problem under moderate sample size (n=1000).
6.2. General model form
In fact, the model can be written in the following general forms:
λ(t |Z) = λ0(tl(β1Z1))l(β1Z1)h(β2Z2(t)) + g(β3Z3(t)), (16)
where l(·), h(·) and g(·) are known functions. The moment based estimator can be
derived from this model exactly the same way as our special case discussed in the main
text. But with different choice of l(·), h(·) and g(·), the interpretation of the parameters
will be different and λ0(t) might no longer be baseline hazard. The estimating equation
can be written as below:
Λ̂0(t;β)
=
∫ t
0
∑
i[dNi(s/l(β1Z1i))− Yi(s/l(β1Z1i))g(β3Z3i(s))/l(β1Z1i)ds]∑
i Yi(s/l(β1Z1i))h(β2Z2i(s))
.(17)
0 =
∑
i
∫
{[Wi(t)−W (t;β)]
[dNi(t/l(β1Z1i))− Yi(t/l(β1Z1i))g(β3Z3i(t))/l(β1Z1i)dt]}, (18)
where W (t;β) =
∑
jWj(t)Yj(t/l(β1Z1i))h(β2Z2j(t))∑
j Yj(t/l(β1Z1i))h(β2Z2j(t))
.
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6.3. Limitations
One limitation for the moment based method is the potential loss of efficiency. For
the moment estimating method, it is suggested that using the partial derivative of log
hazard as weight function will gain more efficiency. However, such weight contains
baseline hazard and its derivative; thus, it is not easy to estimate. Also numerical study
shows that even we plugged in the true baseline to estimate weight, there still can
be efficiency loss comparing to the simple weight Z since the estimating equation
for baseline hazard is not the optimal one as derived from nonparametric maximum
likelihood estimator (NPMLE). Merely changing weight for those equation for β does
not ensure optimal efficiency. Besides efficiency issue, another limitation for the current
method is the use of recursive method to find solution of estimating equations. The
algorithm is slow when sample size is large and the method cannot be applied to high
dimension covariates. One thing that affects the speed is that for this model the W (t)
and W (t) need to be calculated for each time ti exp{β1Zj}. And also, we notice that
when the sample size is too small, there is severe convergence problem, which suggests
that enough data is required to consider such a complex model.
Another limitation of our method is that we assume Z1 to be time independent in
our general model (2). In real application, we might have Z1 be time-varying. How-
ever, there are some issues if we have a time-varying Z1: (1) The interpretation of β1
is difficult since the cumulative hazard will have a rather complicated form; (2) Esti-
mation is not reliable since the proof for the asymptotic result cannot be generalized to
the case whereZ1 is time-varying.
7. Technique Details
Here we give the assumptions we need for the main theory as follows:
• We assume the integral in equation (9) is calculated under some truncation at
time τ which satisfies P (Xi > τeβ10+ζ) ≥ ψ > 0 for all i. If we can find a τ
such that conditions (A), (B) and (D) holds, then this assumption automatically
hold.
• (A) The baseline hazard functionλ0(x) and the density function f(x) = dF (x)/dx
exists and are bounded by K1 for some ζ > 0 for all x < τeβ10+ζ .
• (B) The density of censoring variable C, h(x) = −dH(x)/dx exists and is
bounded by K2 for all x < τeβ10+ζ . (A) and (B) together imply that the density
for variable X exists and is bounded by K = K1 +K2 for all X < τeβ10+ζ .
• (C) There are function θ(u) and a ξ > 0 such that
|λ(u + ǫ)− λ(u)− ǫλ˙(u)| ≤ ǫ2θ(u)
for u ≤ τeβ10 and ǫ ≤ ξ and∫ τeβ10
0
|θ(u)|du <∞.
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• (D) The absolute value of the covariateZi and the weight Wi(t) are bounded by
1 for all subject i on [0, τeβ10+ζ ].
• (E) There is a continuous function µ(u,β) such that
sup
β∈B(β0),u≤τeβ10+ζ
|W (u,β)− µ(u,β)| −→p 0.
• (F) Let
G(β)
= lim
n−→∞
∫ τ
0
n−1
n∑
i=1
(Wi(u)−W (u,β))Yi(ue−β10Z1i)
{−(ue(β10−β1)Z1i λ˙0(ue(β10−β1)Z1i) + λ0(ue(β10−β1)Z1i))eβ20Z2i(u)+(β10−β1)Z1iZ1i
−(β30 − β3)Z3i(u)e−β1Z1iZ1i,−λ0(u)Z2i(u)eβ20Z2i(u),−Z3i(u)e−β10Z1idu}.
There is a matrix of continuous function G(β) such that
sup
β∈B(β0),u≤τeβ10+ζ
‖G(β)−
∫ τ
0
n−1
n∑
i=1
Gi(u)du‖ −→p 0.
where the norm here represents the absolute value for each element.
• (G)Wi(t) converges uniformly in probability to a measurable functions f(Zi, t,β, λ0, data)
respect to Zi, i.e.
sup
β∈B(β0),t∈[0,τeβ10+ζ]
‖Wi − f(Zi, t,β, λ0, X)‖ −→p 0.
We denote W ∗i (t) = f(Zi, t,β, λ0) for simplicity. We assume W ∗i (t) is a con-
tinuous function.
To develop the asymptotic results for our estimator, we follow the proof steps given
in Tsiatis (1990). Denote
dMi(u,β)
= dNi(ue
−β1Z1i)− Yi(ue−β1Z1i)λ0(ue(β10−β1)Z1i)eβ20Z2i(u)+(β10−β1)Z1idu
−Yi(ue−β1Z1i)β30Z3i(u)e−β1Z1idu. (19)
We can write the score function Sn(β, τ) as
n∑
i=1
∫ τ
0
(Wi(u)−W (u,β))dMi(u,β)
+
n∑
i=1
∫ τ
0
(Wi(u)−W (u,β))Yi(ue−β1Z1i)
{λ0(ue(β10−β1)Z1i)eβ20Z2i(u)+(β10−β1)Z1i − λ0(u)eβ2Z2i(u)
+(β30 − β3)Z3i(u)e−β1Z1i}du,
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where the second term can be approximated by a linear form nG(β0)(β − β0). Here
G(·) is defined in Appendix assumption (F). So the score S(β) can be approximated
by
S˜(β) = S(β0) + nG(β0)(β − β0)T + op(1). (20)
We define β̂ as the value that minimize the norm of the score ‖S(β)‖. Here we choose
the L∞ norm for proof. We can also use the L2 norm and since the two norms control
each other, the convergence results will be the same. We define β∗ as the solution of
S˜(β) = 0,then we know that
√
n(β∗ − β0) =
√
nG(β0)
−1S(β0) + op(1), which has
a variance in a sandwich form
V = G(β0)
−1E{S(β0)S(β0)T }G(β0)−T . (21)
We just need to show √n(β̂ − β∗) →p 0. in order to get the asymptotic results for β̂.
Proven by Jureckova (1969, 1971), it would suffice to prove that
sup
‖β−β0‖≤n−1/2C
n−1/2‖S(β)− S˜(β)‖ →p 0,
for any C > 0, which can be derived in three parts. First, we show that for any fixed d,
we have n−1/2(S(β0 + n−1/2d) − S˜(β0 + n−1/2d)) →p 0. Then we show uniform
convergence at a fixed finite number of points that form a mesh from −C to C. If we
have a sequence of d0, d1, · · · , dm, we need show maxn−1/2‖S(β0 + n−1/2di) −
S˜(β0 + n
−1/2di)‖ →p 0. and n−1/2S(β) (as a function of β) do not fluctuate too
greatly within any interval of the mesh. Mathematically, if we have the mesh with size
δ > 0, then we just need to show that for any ǫ > 0, there exist δ > 0 such that
lim
n→∞
P{ sup
dn−1/2≤‖β∗−β0‖≤(d+δ)n−1/2
n−1/2‖S(β∗)− S(β0 + dn−1/2)‖ ≥ ǫ} = 0.
The proof of point-wise convergence is decomposed to the following three lemmas.
Lemma 1 Let βn = (β1n, β2n, β3n) denote a sequence of constant vectors converg-
ing to β0. Then
n−1/2
n∑
i=1
[∫ τ
0
(Wi(u)−W (u,βn))dMi(u,βn)−
∫ τ
0
(Wi(u)− µ(u,βn))dMi(u,βn)
]
converges to 0 in probability, where µ(·) is defined in condition (E).
Lemma 2
n−1/2{
n∑
i=1
∫ τ
0
(Wi(u)−W (u,βn))dMi(u,βn)− S(0)} −→p 0.
Lemma 3
n−1
n∑
i=1
∫ τ
0
(Wi(u)−W (u,βn))Yi(ue−β1nZ1i)
{λ0(ue(β10−β1n)Z1i)eβ20Z2i(u)+(β10−β1n)Z1i − λ0(u)eβ2nZ2i(u)
+(β30 − β3n)Z3i(u)e−βn1Z1i}du
= βn(G(0) + op(1)).
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Proof of Lemma 1: The expression in the Lemma 1 equals to R(τ), where
R(u) = n−1/2
n∑
i=1
∫ u
0
(µ(u,βn)−W (u,βn))dMi(u,βn)
is a martingale. So by Lenglart’s inequality (1977) given by Andersen and Gill (1982),
we have that for each components of the R(u) = (R1(u), R2(u), R3(u))T ,
P (|Rk(u)| > ǫ) ≤ δ/ǫ2 + P (n−1
n∑
i=1
∫ u
0
(µk(u,βn)−W k(u,βn))2Yi(ue−β1nZi)
[λ0(ue
(β10−β1n)Z1i)eβ20Z2i(u)+(β10−β1n)Z1i + β30Z3i(u)e
−β1nZ1i ]du > δ).
By the definition of βn, we can find N sufficiently large such that βN ∈ B(β0) and
‖βN − β0‖ < ζ. Also, by assumption (E), we can find N(ǫ,Kk) such that for any
n > N(ǫ,Kk),
P (sup
u≤τ
|µk(u,βn)−W k(u,βn)| > Kk) < ǫ/6.
So we have, with probability exceeding 1− ǫ/6,∫ τ
0
(µk(u,βn)−W k(u,βn))2Yi(ue−β1nZ1i)
[λ0(ue
(β10−β1n)Z1i)eβ20Z2i(u)+(β10−β1n)Z1i + β30Z3i(u)e
−β1nZ1i ]du)
≤ K2kΛ0(ue|β10−β1n|)eβ20 + β30τ.
For large N , we have |β10 − β1N | < ζ. By truncation assumption, Λ0(ueβ10−β1n) =
− log(S0(ueβ10−β1n)) ≤ − log(ψ), so if we choose Kk ≤
[
δ
− log(ψ)+β30τ
]1/2
, we
have
P (n−1
n∑
i=1
∫ u
0
(µk(u,βn)−W k(u,βn))2Yi(ue−β1nZ1i)
[λ0(ue
(β10−β1n)Z1i)eβ20Z2i(u) + β30Z3i(u)]e
−β1nZ1idu) < ǫ/6.
By choosing δ = ǫ3/6, we have P (|Rk(u)| > ǫ) < ǫ/3. So we have
P (‖R(u)‖ > ǫ) ≤
3∑
k=1
P (|Rk(u)| > ǫ) = ǫ
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Proof of Lemma 2:
n−1/2{
n∑
i=1
∫ τ
0
(Wi(u)−W (u,βn))dMi(u,βn)− S(0)} −→p 0
= n−1/2{
n∑
i=1
∫ τ
0
(Wi(u)−W (u,βn))dMi(u,βn)−
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,βn))dMi(u,βn)}
+n−1/2{
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,βn))dMi(u,βn)−
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,β0))dMi(u,β0)}
+n−1/2{
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,β0))dMi(u,β0)−
n∑
i=1
∫ τ
0
(Wi(u)−W (u,β0))dMi(u,β0)}
The first and third terms converge to 0 in probability by Lemma 1, so we just focus the
second term which we can further decompose to three terms
n−1/2{
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,βn))dMi(u,βn)−
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,β0))dMi(u,β0)}
= n−1/2{
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,βn))dMi(u,βn)−
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,βn))dMi(u,β0)}
+n−1/2{
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,βn))dMi(u,β0)−
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,β0))dMi(u,β0)}
= III + IV.
For term IV, it equals
n−1/2{
n∑
i=1
∫ τ
0
(µ(u,β0)− µ(u,βn))dMi(u,β0)
and by assumption (D), its variance is bounded by
n−1
n∑
i=1
∫ τ
0
(µ(u,β0)− µ(u,βn))2λi(u)P (Xi ≥ u)du
= n−1
n∑
i=1
∫ τ
0
(µ(u,β0)− µ(u,βn))2λi(u)Si(x)Hi(x)du
≤ n−1
n∑
i=1
∫ τ
0
(µ(u,β0)− µ(u,βn))2λi(u)Si(x)du ≤ 4
So by dominated convergence theorem and continuity of µ(·), when βn −→p β, we
have the term IV converge to 0 in probability. For term III, as we have
dMi(ue
(β1n−β10)Zi ,β) = dMi(u,β0),
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So term III can be written as
n−1/2{
n∑
i=1
∫ τe(β1n−β10)Z1i
0
(Wi(ue
(β1n−β10)Z1i)
−µ(ue(β1n−β10)Z1i ,βn))dMi(u,β0)−
n∑
i=1
∫ τ
0
(Wi(u)− µ(u,βn))dMi(u,β0)}
This can be further decomposed to three terms V + V I + V II .
V = n−1/2
n∑
i=1
∫ τ
0
(µ(u,βn)− µ(ue(β1n−β10)Z1i ,βn))dMi(u,β0)
V I = n−1/2
n∑
i=1
∫ τ
0
(Wi(ue
(β1n−β10)Z1i)−Wi(u))dMi(u,β0)
V II = n−1/2
n∑
i=1
∫ τe(β1n−β10)Z1i
τ
(Wi(ue
(β1n−β10)Z1i)− µ(ue(β1n−β10)Z1i ,βn))dMi(u,β0).
Similar to arguments for IV, term V has a bounded variance 4 and thus converges to
0 in probability when βn converges to β0 by dominated convergence theorem and
continuity of µ(·). For term VI, by assumption (G), it is asymptotically equivalent to
n−1/2
n∑
i=1
∫ τ
0
(W ∗i (ue
(β1n−β10)Z1i)−W ∗i (u))dMi(u,β0),
Its variance is
n−1
n∑
i=1
∫ τ
0
(W ∗i (ue
(β1n−β10)Z1i)−W ∗i (u))2λi(u)P (Xi ≥ u)du
≤ n−1
n∑
i=1
∫ τ
0
4λi(u)Si(u)du ≤ 4
So VI converges to 0 in probability when βn converges to β0 by continuity of W ∗i and
dominated convergence theorem.
For term VII, as both Z and W are bounded, it is asymptotically equivalent to
n−1/2
n∑
i=1
∫ τe(β1n−β10)Z1i
τ
(W ∗i (ue
(β1n−β10)Z1i)− µ(ue(β1n−β10)Z1i ,βn))dMi(u,β0)
whose variance is
n−1
n∑
i=1
∫ τe(β1n−β10)Z1i
τ
(W ∗i (ue
(β1n−β10)Z1i)− µ(ue(β1n−β10)Z1i ,βn))2λi(u)P (Xi ≥ u)du
≤ 4n−1
n∑
i=1
∫ τeβ1n−β10
τ
fi(x).
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Since we have
fi(t) ≤ λi(t)
≤ exp{β3t}+ λ0(teβ1Z1)eβ1+β2
≤ exp{β3t}+K1eβ1+β2 ,
the variance of VII is smaller than
4n−1
n∑
i=1
τ(eβ1n−β10 − 1)[exp{β3τeβ1n−β10}+K1eβ1+β2 ]
≤ C(βn1 − β10) −→ 0.
So by the weak law of large number, VII converges to 0 with βn approaching β0.
Combining the results above, we proved Lemma 2.
Proof of Lemma 3: We can decompose the quantity in Lemma 3 to the following
parts.
A1 = n
−1
n∑
i=1
∫ τ
0
(Wi(u)−W (u,βn))Yi(ue−β1nZ1i)
{λ0(ue(β10−β1n)Z1i)eβ20Z2i(u)+(β10−β1n)Z1i − λ0(u)eβ20Z2i(u)+(β10−β1n)Z1i
−u(e(β10−β1n)Z1i − 1)λ˙0(u)eβ20Z2i(u)+(β10−β1n)Z1i}du
≤ eβ20+β10−β1n(u(e(β10−β1n)Z1i − 1))2n−1
n∑
i=1
∫ τ
0
(Wi(u)−W (u,βn))Yi(ue−β1nZ1i)θ(u)du
≤ eβ20+β10−β1n(u(e(β10−β1n)Z1i − 1))2n−1
n∑
i=1
∫ τ
0
(Wi(u)−W (u,βn))2θ(u)du
Since θ(u) is integratable and Wi, W is bounded,A1 →p 0.
A2 = n
−1
n∑
i=1
∫ τ
0
(Wi(u)−W (u,βn))Yi(ue−β1nZ1i)
{u(e(β10−β1n)Z1i − 1− (β10 − β1n)Z1ie(β10−β1n)Z1i)λ˙0(u)eβ20Z2i(u)+(β10−β1n)Z1i}du
≤ (β10 − β1n)2n−1
n∑
i=1
∫ τ
0
|Wi(u)−W (u,βn)|Yi(ue−β1nZ1i)|λ˙0(u)|eβ20+(β10−β1n)du
Since each term in the integral is bounded with probability 1, we have A2 →p 0.
A3 = n
−1
n∑
i=1
∫ τ
0
(Wi(u)−W (u,β))Yi(ue−β1nZ1i)
{λ0(u)eβ2nZ2i(u) − λ0(u)eβ20Z2i(u) − λ0(u)eβ20Z2i(u)(β2n − β20)Z2i}du
≤ (β2n − β20)2n−1
n∑
i=1
∫ τ
0
|Wi(u)−W (u,β)|λ0(u)eβ20du
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and
A4 = n
−1
n∑
i=1
∫ τ
0
(Wi(u)−W (u,β))Yi(ue−β1nZ1i){(β30 − β3n)Z3i(u)e−β1Z1i}du
Since Wi is bounded, it is easy to obtain both A3 and A4 converge to 0 in probability,
so the Lemma 3 holds.
Combining Lemma 1-3 and let βn = β0 + n−1/2d, we proved the point-wise con-
vergence. Then we count the number of sign interchanges caused by a small change
in β to show that the score function converges uniformly. The score has partial deriva-
tive respect to β2 and β3, so the slight change in those two dimension will not cause
problem. We just need to show that the change in β1 with δ size cause only bounded
interchange and for each interchange, the change in statistics are bounded for any fixed
β2 and β3 near the true β. We rank the β1Z1i and use same subscript (i) for all vari-
ables.
The score can be written as
S(β) =
∑
i
∫
{(W(i) −W (i))[dN(i)(te−β1Z1(i))− Y(i)(te−β1Z1(i))β3Z3(i)(t)e−β1Z1(i)dt]}
=
∑
i
(W(i) −W (i))∆(i) −
∑
(i)
∫
{(W(i) −W (i))[Y(i)(te−β1Z1(i))β3Z3i(t)e−β1Z1(i)dt]},
where W (i)(β) = W (i)(β, t(i)). The change of β causes change of β in two ways.
We consider change β1 in the term dN(·) and Y (·) separately from that change in
term like β3Z3i(t)eβ1Z1(i) . As the score is derivable with respect to the parameter in
the term like β3Z3i(t)eβ1Z1(i) , we just need to show it is also bounded when it causes
change in dN(·) and Y (·) but fixed the parameter in other parts. We have W(i) =∑
j>iW(j)(t(i))e
β2Z2(j)
∑
j>i e
β2Z2(j)
. So an interchange can cause the following quantity change in∑
i(W(i) −W (i))∆(i) similar to that derived by Tsiatis (3.15).
∆(j+1){W(j+1) −W (j)}+∆(j){W(j) −
W (j+2)
∑
i>j e
β2Z2(i) +W (j)e
β2Z2(j)∑
i>j e
β2Z2(i)
}
−∆(j+1){W(j+1) −W (j+1)} −∆(j){W(j) −W (j)}
= ∆(j+1)(W (j+1) −W(j+1))
eβ2Z2(j+1)∑
i>j e
β2Z2(i)
+∆(j)(W (j) −W (j+2))
∑
i>j+1 e
β2Z2(i)∑
i>j e
β2Z2(i)
= {∆(j+1) −∆(j)}(W (j+1) −W(j+1) −W (j) +W (j+2))
eβ2Z2(j+1)−β1Z1(j+1)∑
i>j e
β2Z2(i)−β1Z1(i)
+∆(j)
W(j+2)e
β2Z2(j+2) +W(j+1)e
β2Z2(j+1)∑
i>j e
β2Z2(i)
.
By assumption (D), we have that (W (j+1) −W(j+1) −W (j) +W (j+2)) is bounded
by 4, ∆(j+1)−∆(j) is bounded by 2, and e
β2Z2(j+1)
∑
i>j e
β2Z2(i)
bounded by 2eβ2/(N − j). So
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the overall change for the first part is bounded by 16eβ2/(N − j) + 4eβ2/(N − j) =
20eβ2/(N − j). By truncation assumption, N − j should be in the same order as N
because more than Nψ subject tend to be alive at τeβ10 . So the quantity changed in
score by one interchange is in the order of O(1/N).
Now we calculate the change in second term∑
(i)
∫
{(W(i)(u)−W (u))[Y(i)(e−β1Z1(i))β3Z3(i)(u)e−β1Z1(i)du.
As an integration of Y (u), the change in Y (u) only occurs at finite points, so∑
(i)
∫
{W(i)(u)[Y(i)(e−β1Z1(i))β3Z3(i)(u)e−β1Z1(i)du
does not change. For the second term, it equals to
−
∫
{W (u)
∑
i
[Y(i)(e
−β1Z1(i))β3Z3(i)(u)e
−β1Z1(i)du.
For an interchange, the change in W (u) is uniformly bounded by O(1/N) as shown in
the first part.
Same as Tsiatis (1990), we have
lim
N−→∞
P (N−3/2M ≤ ǫ) = 0,
if we choose δ = O(ǫ). Combining these results, we show the uniform convergence
and thus obtain the asymptotic result we want.
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